|
FR2553287B1
(fr)
*
|
1983-10-18 |
1986-09-12 |
Choay Sa |
Compositions a base de mucopolysaccharides ou d'oligosaccharides, notamment a base de fractions ou fragments d'heparine, appropriees au traitement de desordres de la proliferation cellulaire
|
|
DE3432661A1
(de)
*
|
1984-09-05 |
1986-03-06 |
Albert Prof. Dr. 6907 Nußloch Landsberger |
Carcinom-therapeutikum
|
|
US4771042A
(en)
*
|
1985-11-25 |
1988-09-13 |
The Upjohn Company |
Inhibition of angiogenesis involving the coadministration of steroids with heparin or heparin fragments
|
|
ATE82126T1
(de)
*
|
1986-04-04 |
1992-11-15 |
Angiogenics Ltd |
Zubereitung zum stoppen von angiogenese und einem kapillar-, zellen- oder membranleck.
|
|
US4966890A
(en)
*
|
1986-04-04 |
1990-10-30 |
Angiogenics, Ltd. |
Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
|
|
US4820693A
(en)
*
|
1986-05-22 |
1989-04-11 |
Angiogenics, Ltd. |
Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
|
|
FR2597484B1
(fr)
*
|
1986-04-17 |
1988-12-23 |
Sanofi Sa |
Glycosaminoglycanes de type heparine ou heparane-sulfate dotes d'une activite sur la division et la differentiation cellulaires, leur preparation et leurs applications therapeutiques.
|
|
IE61758B1
(en)
*
|
1986-05-23 |
1994-11-30 |
Daiichi Seiyaku Co |
Use of a sulfated polysaccharide
|
|
IL79255A0
(en)
*
|
1986-06-26 |
1986-09-30 |
Hadassah Med Org |
Composition for metastasis prevention
|
|
US5206223A
(en)
*
|
1986-06-26 |
1993-04-27 |
Yeda Research And Development Co. Ltd. |
Method for inhibiting heparanase activity
|
|
IL85145A
(en)
*
|
1987-01-23 |
1994-08-26 |
Univ Australian |
Anti-metastatic pharmacological or veterinary preparations containing modified herpin with reduced anticoagulant activity
|
|
US5541166A
(en)
*
|
1987-01-23 |
1996-07-30 |
The Australian National University |
Sulphated polysaccharides having anti-metastatic and/or anti-inflammatory activity
|
|
US5668116A
(en)
*
|
1987-03-19 |
1997-09-16 |
Anthropharm Pty. Limited |
Anti-inflammatory compounds and compositions
|
|
AU604542B2
(en)
*
|
1987-03-19 |
1990-12-20 |
Arthropharm Pty Ltd |
Polysulphated polysaccharide complexes
|
|
JPH03502105A
(ja)
*
|
1988-11-01 |
1991-05-16 |
チルドレンズ メヂカル センター コーポレイション |
抗血栓性ステロイド
|
|
US6090794A
(en)
*
|
1990-04-19 |
2000-07-18 |
The General Hospital Corporation |
Inhibition of neurofibrosarcoma growth and angiogenesis
|
|
US5733892A
(en)
*
|
1990-07-24 |
1998-03-31 |
Seikagaku Corporation |
Metastasis inhibitor composition comprising a phospholipid-linked glycosaminoglycan and method for inhibiting metastasis employing the same
|
|
CA2067211C
(en)
*
|
1990-07-24 |
2004-06-15 |
Katsukiyo Sakurai |
Phospholipid- or lipid-linked glycosaminoglycan, process for producing the same and metastasis inhibitor
|
|
US5514667A
(en)
*
|
1990-11-05 |
1996-05-07 |
Arthropharm Pty. Limited |
Method for topical treatment of herpes infections
|
|
KR100235782B1
(ko)
*
|
1991-05-02 |
1999-12-15 |
파울리나 벤-아미 |
병리학적 과정의 예방 또는 치료를 위한 성분물
|
|
US6750207B1
(en)
|
1992-05-01 |
2004-06-15 |
Yeda Research And Development Co. Ltd. |
Compositions for the regulation of cytokine activity
|
|
US5861382A
(en)
*
|
1992-05-01 |
1999-01-19 |
Yeda Research And Development Co. Ltd. |
Methods for regulation of active TNF-α
|
|
AU3968597A
(en)
|
1996-08-02 |
1998-02-25 |
Children's Medical Center Corporation |
Method of regulating the female reproductive system through angiogenesis inhibitors
|
|
US7056504B1
(en)
|
1998-08-27 |
2006-06-06 |
Massachusetts Institute Of Technology |
Rationally designed heparinases derived from heparinase I and II
|
|
AU4351201A
(en)
|
2000-03-08 |
2001-09-17 |
Massachusetts Inst Technology |
Heparinase iii and uses thereof
|
|
US6969705B2
(en)
|
2000-07-21 |
2005-11-29 |
Aventis Pharma S.A. |
Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
|
|
DE10141749A1
(de)
*
|
2000-08-29 |
2002-03-14 |
Max Delbrueck Centrum |
Mittel zur Beeinflussung der Angiogenese
|
|
CA2423469A1
(en)
|
2000-10-18 |
2002-04-25 |
Massachusetts Institute Of Technology |
Methods and products related to pulmonary delivery of polysaccharides
|
|
US7285536B2
(en)
|
2001-12-05 |
2007-10-23 |
Yeda Research And Development Co., Ltd. |
Anti-cancer therapeutic compounds
|
|
US20040171819A1
(en)
|
2002-10-10 |
2004-09-02 |
Aventis Pharma S.A. |
Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
|
|
US7956046B2
(en)
|
2003-07-24 |
2011-06-07 |
Aventis Pharma S.A. |
Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
|
|
WO2005082376A1
(en)
*
|
2004-02-26 |
2005-09-09 |
Advanced Ocular Systems Limited |
Tetracycline derivatives for the treatment of ocular pathologies
|
|
NZ589444A
(en)
|
2008-05-28 |
2013-03-28 |
Validus Biopharma Inc |
NON-HORMONAL STEROID MODULATORS OF NF-Kappa B FOR TREATMENT OF DISEASE
|
|
EP2556083A4
(en)
|
2010-04-05 |
2013-12-04 |
Validus Biopharma Inc |
NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT
|
|
US10034921B2
(en)
|
2013-02-13 |
2018-07-31 |
Laboratoire Français Du Fractionnement Et Des Biotechnologies |
Proteins with modified glycosylation and methods of production thereof
|
|
WO2017004205A1
(en)
|
2015-06-29 |
2017-01-05 |
Reveragen Biopharma, Inc. |
NON-HORMONAL STEROID MODULATORS OF NF-κB FOR TREATMENT OF DISEASE
|
|
US11382922B2
(en)
|
2019-03-07 |
2022-07-12 |
Reveragen Biopharma, Inc. |
Aqueous oral pharmaceutical suspension compositions
|